shot-button
Subscription Subscription
Home > News > India News > Article > Mild disease no severity among Indian patients INSACOG on Omicrons XBB variant

Mild disease, no severity among Indian patients: INSACOG on Omicron's XBB variant

Updated on: 02 November,2022 02:58 PM IST  |  New Delhi
PTI |

The expert panel said the XBB variant has been detected in multiple states in the country

Mild disease, no severity among Indian patients: INSACOG on Omicron's XBB variant

Representative image

Indian patients infected with Omicron sub-lineage XBB of COVID-19 have mild disease and no increase in severity is noted, the INSACOG said.


The expert panel said the XBB variant has been detected in multiple states in the country.



The Indian SARS-CoV-2 Genomics Consortium (INSACOG), in a statement, said it is keeping a close watch and monitoring the emergence and evolution of XBB and XBB.1 and any new sub-lineages.


"The community need not panic and adherence to coronavirus appropriate behaviour is recommended in the light of ongoing festivities," it said.

Among the Indian patients the disease is mild like with other Omicron sub-lineages and no increase in severity is noted, the panel said.

Also read: 29 new Covid-19 cases in Thane; active tally at 298

In the current phase of the pandemic, the INSACOG said the SARS-CoV-2 virus is continuously accumulating mutations, some of which might contribute to increased transmissibility and immune evasion resulting in transmission advantage over other variants.

"XBB, a BJ.1/BM.1.1.1 recombinant lineage with breakpoint in the spike protein is presently appearing in multiple countries. This recombinant lineage was first detected in Singapore and the US, and has also been identified in multiple states in India," it said.

A sub-lineage of XBB with an additional mutation is also detected (XBB.1).

"Modest increase in the spread of XBB in Singapore has been observed. However, there has been no report of increase in severity of disease or increase in hospitalisation associated with these variants," it added.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK